Analytical and Clinical Validation of a Target-Enhanced Whole Genome Sequencing-Based Comprehensive Genomic Profiling Test
Authors:
Open Access
- 21 May 2024
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 42 (5) , 390-399
Abstract
Evaluation of the test performance of the Target enhanced whole-genome sequencing (TE-WGS) assay for comprehensive oncology genomic profiling. The analytical validation of the assay included sensitivity and specificity for single nucleotide variants (SNVs), insertions/deletions (indels), and structural variants (SVs), revealing a revealed a sensitivity of 99.8% for SNVs and 99.2% for indels. The positive predictive value (PPV) was 99.3% SNVs and 98.7% indels. Clinical validation was benchmarked against established orthogonal methods and demonstrated high concordance with reference methods. TE-WGS provides insights beyond targeted panels by comprehensive analysis of key biomarkers and the entire genome encompassing both germline and somatic findings.Keywords
Funding Information
- the Bio & Medical Technology Development Program of the National Research Foundation
- Korean government (2022M3A9G101451221)
This publication has 18 references indexed in Scilit:
- Observed versus modelled lifetime overall survival of targeted therapies and immunotherapies for advanced non-small cell lung cancer patients – A systematic reviewCritical Reviews in Oncology/Hematology, 2020
- Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal SpecimensJAMA Network Open, 2020
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinicAnnals of Oncology, 2018
- Strelka2: fast and accurate calling of germline and somatic variantsNature Methods, 2018
- A method to reduce ancestry related germline false positives in tumor only somatic variant callingBMC Medical Genomics, 2017
- Manta: rapid detection of structural variants and indels for germline and cancer sequencing applicationsBioinformatics, 2015
- Clinical next‐generation sequencing in patients with non–small cell lung cancerCancer, 2014
- SAMBLASTER: fast duplicate marking and structural variant read extractionBioinformatics, 2014
- MSIsensor: microsatellite instability detection using paired tumor-normal sequence dataBioinformatics, 2013
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010